AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)

This study has been completed.
Sponsor:
Information provided by:
Hospital de Base
ClinicalTrials.gov Identifier:
NCT00780845
First received: October 27, 2008
Last updated: November 3, 2008
Last verified: October 2008
  Purpose

The purpose of this study is evaluate clinical outcomes and 30-day mortality after on-pump CABG.


Condition
Kidney Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: AKIN (Acute Kidney Injury Network): Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft Surgery

Resource links provided by NLM:


Further study details as provided by Hospital de Base:

Primary Outcome Measures:
  • To test the hypothesis that patients with acute kidney injury after on-pump CABG have higher 30-day mortality [ Time Frame: 30 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To compare clinical outcomes in patients with and without acute kidney injury after on-pump CABG [ Time Frame: 30 days ] [ Designated as safety issue: No ]

Enrollment: 817
Study Start Date: January 2003
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
AKI (-)
Patients without acute kidney injury after on-pump CABG
AKI (+)
Patients with acute kidney injury after on-pump CABG

Detailed Description:

Eight hundred and seventeen patients was enrolled in this series and divided into to groups: Group AKI (-) - patients without acute kidney injury after on-pump CABG. Group AKI (+) - patients with acute kidney injury after on-pump CABG. AKI was defined as an absolute increase in serum creatinine (SCr) of more than or equal to 0.3 mg/dl (≥ 26.4 μmol/l) or a percentage increase in SCr of more than or equal to 50% (1.5-fold from baseline). The change in SCr concentration was defined as the difference between immediate postoperative concentration and the highest concentration during the stay in ICU. Clinical Outcomes and 30-day mortality was evaluate in this patients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Groups AKI (-) and AKI (+) selected consecutively after admission in cardiac surgery postoperative care unit

Criteria

Inclusion Criteria:

  • Patients underwent on-pump coronary artery bypass grafting
  • Patients with at least two serum creatinine values within 48 hours.

Exclusion Criteria:

  • Patients with end-stage kidney disease requiring renal replacement therapy.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00780845

Sponsors and Collaborators
Hospital de Base
Investigators
Study Director: Lilia N Maia, PhD São José do Rio Preto Medical School
  More Information

No publications provided by Hospital de Base

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Mauricio N Machado, São José do Rio Preto Medical School
ClinicalTrials.gov Identifier: NCT00780845     History of Changes
Other Study ID Numbers: CAAE-3438.0.000.140-08
Study First Received: October 27, 2008
Last Updated: November 3, 2008
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Hospital de Base:
Acute Kidney failure
Clinical outcomes
On-pump
Coronary artery bypass grafting
Morbidity
Mortality

Additional relevant MeSH terms:
Acute Kidney Injury
Renal Insufficiency
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on September 29, 2014